Pure Biologics Spólka Akcyjna
PUR.WA · WSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | PLN 88,330 | PLN 40,315 | PLN 51,086 | PLN 172,803 |
| - Cash | PLN 313 | PLN 3,606 | PLN 2,259 | PLN 6,178 |
| + Debt | PLN 14,059 | PLN 12,938 | PLN 2,861 | PLN 3,113 |
| Enterprise Value | PLN 102,076 | PLN 49,647 | PLN 51,688 | PLN 169,738 |
| Revenue | PLN 0 | PLN 95 | PLN 662 | PLN 254 |
| % Growth | -100% | -85.6% | 160.6% | – |
| Gross Profit | -PLN 46 | -PLN 2,574 | -PLN 5,407 | -PLN 4,027 |
| % Margin | – | -2,709.5% | -816.8% | -1,585.4% |
| EBITDA | -PLN 12,244 | -PLN 26,077 | -PLN 22,777 | -PLN 8,618 |
| % Margin | – | -27,449.5% | -3,440.6% | -3,392.9% |
| Net Income | -PLN 19,435 | -PLN 35,694 | -PLN 26,372 | -PLN 13,071 |
| % Margin | – | -37,572.6% | -3,983.7% | -5,146.1% |
| EPS Diluted | -3.78 | -11.19 | -11.87 | -5.88 |
| % Growth | 66.2% | 5.7% | -101.9% | – |
| Operating Cash Flow | -PLN 10,829 | -PLN 23,262 | -PLN 17,387 | -PLN 24,035 |
| Capital Expenditures | PLN 0 | -PLN 176 | -PLN 5,758 | -PLN 673 |
| Free Cash Flow | -PLN 10,829 | -PLN 23,438 | -PLN 23,145 | -PLN 24,708 |